Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-05-17 @ 6:02 PM
Study NCT ID:
NCT07120451
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-13
First Post:
2025-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
Sponsor:
Organization: